News tagged with hepatitis
Administration of meningococcal vaccine with other routine infant vaccines appears effective
Administration of routine infant immunizations with a vaccine for serogroup B Neisseria meningitidis, a bacterium that is a cause of serious disease such as sepsis and meningitis, was effective against meningococcal strains ...
Feb 07, 2012 |
5 / 5 (1) |
0
|
US recommends routine HPV vaccination for boys
US health authorities on Friday urged all boys age 11-12 to get a routine vaccination against the most common sexually transmitted disease, human papillomavirus, or HPV.
Feb 03, 2012 |
5 / 5 (1) |
0
Coffee consumption reduces fibrosis risk in those with fatty liver disease
Caffeine consumption has long been associated with decreased risk of liver disease and reduced fibrosis in patients with chronic liver disease. Now, newly published research confirms that coffee caffeine consumption reduces ...
Feb 02, 2012 |
5 / 5 (1) |
0
Stem cells could drive hepatitis research forward
Hepatitis C, an infectious disease that can cause inflammation and organ failure, has different effects on different people. But no one is sure why some people are very susceptible to the infection, while ...
Feb 01, 2012 |
5 / 5 (1) |
0
|
2012 adult immunization schedule broadens recommendations for HPV and hepatitis B vaccinations
The CDC's Advisory Committee on Immunization Practices (ACIP) now recommends routine HPV vaccination for males aged 11 to 12 years and catch-up vaccination for males aged 13 to 21. These are just two of the changes to the ...
Feb 01, 2012 |
5 / 5 (1) |
0
Researchers indentify a cell-permeable peptide that inhibits hepatitis C
Researchers from UCLA's Jonsson Comprehensive Cancer Center have identified a cell-permeable peptide that inhibits a hepatitis C virus protein and blocks viral replication, which can lead to liver cancer and cirrhosis.
Jan 31, 2012 |
not rated yet |
0
|
Entry point for hepatitis C infection identified
A molecule embedded in the membrane of human liver cells that aids in cholesterol absorption also allows the entry of hepatitis C virus, the first step in hepatitis C infection, according to research at the University of ...
Jan 24, 2012 |
4.5 / 5 (2) |
0
|
Many high-risk Americans don't get hepatitis B vaccine
Although there is an effective vaccine for hepatitis B and public health officials have a strong sense of who is at highest risk for the infectious liver disease, tens of thousands of people in the United ...
Jan 19, 2012 |
not rated yet |
0
|
Combination of oral drugs suppresses common type of hepatitis C
A new combination of investigational drugs successfully suppressed hepatitis C genotype 1 infection in a high percent of patients who had not responded to previous treatment in a study led by a University of Michigan hepatologist.
Jan 19, 2012 |
not rated yet |
0
|
Scientists show brain vulnerable to Hepatitis C virus
(Medical Xpress) -- Scientists at the University of Birmingham have demonstrated for the first time that human brain cells can become infected with the Hepatitis C virus (HCV), it is reported today.
Jan 18, 2012 |
5 / 5 (2) |
0
Researchers identify potential new therapy approach for hepatitis C
Researchers at the University of British Columbia have found a new way to block infection from the hepatitis C virus (HCV) in the liver that could lead to new therapies for those affected by this and other infectious diseases.
Jan 16, 2012 |
not rated yet |
0
|
New fibrosis classification improves accuracy of diagnosis in hepatitis C
A new classification for diagnosing fibrosis in patients with chronic hepatitis C virus (HCV) has shown to be as accurate as currently used algorithms, but required no further liver biopsy. The study appearing in the January ...
Jan 10, 2012 |
not rated yet |
0
High rates of disability and health care use for older Americans with cirrhosis
New research shows that older Americans with cirrhosis have significantly worse health status and greater functional disability compared to those without this potentially deadly disease. In fact, findings now published in ...
Jan 10, 2012 |
not rated yet |
0
Bristol-Myers Squibb to buy Inhibitex for $2.5 billion
Pharmaceutical giant Bristol-Myers Squibb Company announced it was acquiring Inhibitex, Inc., a company specializing in treatment of hepatitis C, for $2.5 billion (1.9 billion euros).
Medicine & Health / Medications
Jan 08, 2012 |
not rated yet |
0
First trial of a new hepatitis C vaccine shows promise
(Medical Xpress) -- A new vaccine against the chronic liver disease hepatitis C has shown promising results in a first clinical trial in humans, Oxford University researchers report.
Jan 05, 2012 |
5 / 5 (4) |
0
|
Hepatitis
Hepatitis (plural hepatitides) implies injury to the liver characterized by the presence of inflammatory cells in the tissue of the organ. The name is from ancient Greek hepar (ἧπαρ), the root being hepat- (ἡπατ-), meaning liver, and suffix -itis, meaning "inflammation" (c. 1727). The condition can be self-limiting, healing on its own, or can progress to scarring of the liver. Hepatitis is acute when it lasts less than six months and chronic when it persists longer. A group of viruses known as the hepatitis viruses cause most cases of liver damage worldwide. Hepatitis can also be due to toxins (notably alcohol), other infections or from autoimmune process. It may run a subclinical course when the affected person may not feel ill. The patient becomes unwell and symptomatic when the disease impairs liver functions that include, among other things, removal of harmful substances, regulation of blood composition, and production of bile to help digestion.
For more information about Hepatitis, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
